Volume 23 Issue 12
Dec.  2025
Turn off MathJax
Article Contents
CHEN Shixuan, CHEN Zhenzhen, CHEN Wenci, JI Jing. Causal association between iron homeostasis and functional outcome after ischemic stroke: a two-sample univariate and multivariate Mendelian randomization study[J]. Chinese Journal of General Practice, 2025, 23(12): 2017-2021. doi: 10.16766/j.cnki.issn.1674-4152.004281
Citation: CHEN Shixuan, CHEN Zhenzhen, CHEN Wenci, JI Jing. Causal association between iron homeostasis and functional outcome after ischemic stroke: a two-sample univariate and multivariate Mendelian randomization study[J]. Chinese Journal of General Practice, 2025, 23(12): 2017-2021. doi: 10.16766/j.cnki.issn.1674-4152.004281

Causal association between iron homeostasis and functional outcome after ischemic stroke: a two-sample univariate and multivariate Mendelian randomization study

doi: 10.16766/j.cnki.issn.1674-4152.004281
Funds:

 2021ZB276

 Y20240897

  • Received Date: 2024-12-25
    Available Online: 2026-03-13
  •   Objective  Observational studies suggest an association between serum iron homeostasis and functional outcome after ischemic stroke, but this association is susceptible to confounders and reverse causality. This study utilizes Mendelian randomization (MR) to minimize confounders and assess whether an imbalance in iron homeostasis is causally associated with poor functional outcome after ischemic stroke.  Methods  GWAS data related to iron homeostasis, including serum iron, ferritin, total iron-binding capacity, transferrin saturation, and liver iron content, were selected as exposure variables. GWAS data on functional outcome at three months after ischemic stroke were used as outcome variables. Firstly, univariable MR (UVMR) analysis was conducted, with the random effects inverse variance weighting (IVW) serving as the primary analysis method, and MR-Egger and weighted median (WME) methods as supplementary analyses. Cochran's Q and Rucker's Q tests were employed to assess heterogeneity, while the MR-Egger intercept was used to test for horizontal pleiotropy. Additionally, multivariable MR (MVMR) analysis was performed to evaluate the causal effect after adjusting for BMI.  Results  A total of 117 single nucleotide polymorphisms (SNPs) were ultimately selected as instrumental variables for iron homeostasis, with all SNPs having an F-value greater than 10. The UVMR-IVW results indicated a causal association between serum iron, transferrin saturation, liver iron content, and poor functional outcome at three months after ischemic stroke (P < 0.05). The MVMR-IVW results, adjusted for BMI, showed that serum iron and transferrin saturation maintained significant causal associations with poor functional outcome at three months after ischemic stroke (P < 0.05). All results from MR-Egger and WME methods were consistent with IVW, and no evidence of heterogeneity or horizontal pleiotropy was found.  Conclusion  There is a significant causal association between serum iron overload and poor functional outcome at three months after ischemic stroke.

     

  • loading
  • [1]
    王陇德, 彭斌, 张鸿祺, 等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志, 2022, 19(2): 136-144.

    WANG L D, PENG B, ZHANG H Q, et al. Brief report on stroke prevention and treatment in China, 2020[J]. Chin J Cerebrovasc Dis, 2022, 19(2): 136-144.
    [2]
    HAN J, ZHANG J, YAO X, et al. Mechanism of HDAC1 regulating iron overload-induced neuronal oxidative damage after cerebral hemorrhage[J]. Mol Neurobiol, 2024, 61(10): 7549-7566. doi: 10.1007/s12035-024-04000-2
    [3]
    SAKIB A A, MIAH M, ALAM M K, et al. Relation of serum ferritin level with severity of neurological disability among patients with acute ischemic stroke[J]. Mymensingh Med J, 2024, 33(4): 973-979.
    [4]
    陈娟, 陈世宣, 王丰, 等. 血清铁相关指标与脑卒中后认知障碍风险的相关性[J]. 中华全科医学, 2024, 22(11): 1876-1879. doi: 10.16766/j.cnki.issn.1674-4152.003754

    CHEN J, CHEN S X, WANG F, et al. Correlation analysis between serum iron-related indicators and the risk of post-stroke cognitive impairment in stroke patients[J]. Chinese Journal of General Practice, 2024, 22(11): 1876-1879. doi: 10.16766/j.cnki.issn.1674-4152.003754
    [5]
    YEH S J, CHEN C H, LIN Y H, et al. Association of ferroptosis with severity and outcomes in acute ischemic stroke patients undergoing endovascular thrombectomy: a case-control study[J]. Mol Neurobiol, 2023, 60(10): 5902-5914. doi: 10.1007/s12035-023-03448-y
    [6]
    WU Q, WEI C, LIU J, et al. Effects of hyperferritinemia on functional outcome in acute ischemic stroke patients with admission hyperglycemia[J]. Cerebrovasc Dis, 2023, 52(5): 511-518. doi: 10.1159/000527860
    [7]
    RICHMOND R C, DAVEY S G. Mendelian randomization: concepts and scope[J]. Cold Spring Harb Perspect Med, 2022, 12(1): a40501. DOI: 10.1101/cshperspect.a040501.
    [8]
    BELL S, RIGAS A S, MAGNUSSON M K, et al. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis[J]. Commun Biol, 2021, 4(1): 156. DOI: 10.1038/s42003-020-01575-z.
    [9]
    LIU Y, BASTY N, WHITCHER B, et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning[J]. Elife, 2021, 10(6): e65554. DOI: 10.7554/eLife.65554.
    [10]
    SODERHOLM M, PEDERSEN A, LORENTZEN E, et al. Genome-wide association meta-analysis of functional outcome after ischemic stroke[J]. Neurology, 2019, 92(12): e1271-e1283.
    [11]
    CHEN S, CHEN Z, XU Q, et al. Dual effects of serum urate on stroke risk and prognosis: insights from Mendelian randomization[J]. Front Neurol, 2024, 15: 1359292. DOI: 10.3389/fneur.2024.1359292.
    [12]
    TIAN Y, TIAN Y, YUAN Z, et al. Iron metabolism in aging and age-related diseases[J]. Int J Mol Sci, 2022, 23(7): 3612. DOI: 10.3390/ijms23073612.
    [13]
    FAN X, LI A, YAN Z, et al. From iron metabolism to ferroptosis: pathologic changes in coronary heart disease[J]. Oxid Med Cell Longev, 2022, 2022(8): 6291889. DOI: 10.1155/2022/6291889.
    [14]
    HU H, CHEN Y, JING L, et al. The link between ferroptosis and cardiovascular diseases: a novel target for treatment[J]. Front Cardiovasc Med, 2021, 8(7): 710963. DOI: 10.3389/fcvm.2021.710963.
    [15]
    LEVI S, RIPAMONTI M, MORO A S, et al. Iron imbalance in neurodegeneration[J]. Mol Psychiatry, 2024, 29(4): 1139-1152. doi: 10.1038/s41380-023-02399-z
    [16]
    BU Z Q, YU H Y, WANG J, et al. Emerging role of ferroptosis in the pathogenesis of ischemic stroke: a new therapeutic target?[J]. ASN Neuro, 2021, 13: 523058879. DOI: 10.1177/17590914211037505.
    [17]
    MAO H, DOU W, WANG X, et al. Iron deposition in fray matter nuclei of patients with intracranial artery stenosis: a quantitative susceptibility mapping study[J]. Front Neurol, 2021, 12: 785822. DOI: 10.3389/fneur.2021.785822.
    [18]
    KATAIKE V M, DESMOND P M, STEWARD C, et al. Iron changes within infarct tissue in ischemic stroke patients after successful reperfusion quantified using QSM[J]. Neuroradiology, 2024, 66(12): 2233-2242. doi: 10.1007/s00234-024-03444-6
    [19]
    JIN Y, HUANG Y H, CHEN Y P, et al. Combined effect of cortical superficial siderosis and cerebral microbleed on short-term and long-term outcomes after intracerebral haemorrhage[J]. Stroke Vasc Neurol, 2024, 9(4): 429-438. doi: 10.1136/svn-2023-002439
    [20]
    RAJENDRAN S R, PERIYASAMY S, MANJULADEVI M T, et al. Evaluation of serum ferritin as a prognostic marker in acute hemorrhagic stroke[J]. J Neurosci Rural Pract, 2020, 11(1): 72-77.
    [21]
    SAKIB A A, MIAH M, ALAM M K, et al. Relation of serum ferritin level with severity of neurological disability among patients with acute ischemic stroke[J]. Mymensingh Med J, 2024, 33(4): 973-979.
    [22]
    HE Q, WANG W, XU D, et al. Causal association of iron status with functional outcome after ischemic stroke[J]. Stroke, 2024, 55(2): 423-431. doi: 10.1161/STROKEAHA.123.044930
    [23]
    DU B, DENG Z, CHEN K, et al. Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke[J]. Genes Dis, 2024, 11(6): 101262. DOI: 10.1016/j.gendis.2024.101262.
    [24]
    MILLAN M, DEGREGORIO-ROCASOLANO N, PEREZ D L O N, et al. Targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: safety and optimal dose selection in a randomized clinical trial[J]. Antioxidants(Basel), 2021, 10(8): 1270. DOI: 10.3390/antiox10081270.
    [25]
    DELGADO-MARTIN S, MARTINEZ-RUIZ A. The role of ferroptosis as a regulator of oxidative stress in the pathogenesis of ischemic stroke[J]. FEBS Lett, 2024, 598(17): 2160-2173. doi: 10.1002/1873-3468.14894
    [26]
    YE Y, XIE X, BI Y, et al. Naoqing formula alleviates acute ischaemic stroke-induced ferroptosis via activating Nrf2/xCT/GPX4 pathway[J]. Front Pharmacol, 2024, 15: 1525456. DOI: 10.3389/fphar.2024.1525456.
    [27]
    ZHAO Y, LIU Y, XU Y, et al. The role of ferroptosis in blood-brain barrier injury[J]. Cell Mol Neurobiol, 2023, 43(1): 223-236. doi: 10.1007/s10571-022-01197-5
    [28]
    ZHAO Y, YANG M, LIANG X. The role of mitochondria in iron overload-induced damage[J]. J Transl Med, 2024, 22(1): 1057. DOI: 10.1186/s12967-024-05740-4.
    [29]
    NADGAUDA K P, METGUD D C, BELLAD R M, et al. Exploring the association between haematological markers of iron and general movements in 4-month-old infants exposed to anaemia in-utero[J]. Early Hum Dev, 2024, 195: 106080. DOI: 10.1016/j.earlhumdev.2024.106080.
    [30]
    MAIO N, SANETO R P, STEET R, et al. Disruption of cellular iron homeostasis by IREB2 missense variants causes severe neurodevelopmental delay, dystonia and seizures[J]. Brain Commun, 2022, 4(3): fcac102. DOI: 10.1093/braincomms/fcac102.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (10) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return